News & Media

News
July 11, 2022
Optimizing Process Development Early – A critical factor in successful viral vector scale up and large scale manufacture
Blog
November 28, 2022
Following pre-clinical and clinical success, adeno-associated viral vectors (AAVs), have become a leading tool for gene delivery in the treatment...
News
July 11, 2022
John Ketz and Denis Kole speak with Brandy Sargent on The Cell Culture Dish podcast about viral vector production, including current manufacturing challenges, navigating the road to commercialization, and successful scale up strategies.
Blog
February 28, 2022
Observed every year on the last day in February, Rare Disease Day works to raise awareness for rare diseases and...
News
February 14, 2022
Mayo Pujols, CEO of Andelyn Biosciences, discusses how Cell & Gene companies are focusing on reliability and predictability to further advance this innovative therapy.
Blog
February 11, 2022
Every day here at Andelyn Biosciences is Women in Science Day! We are proud that 50% of our scientists on...
Blog
February 8, 2022
Gene therapies offer an unprecedented ability to treat — and even cure — genetic diseases, and their potential spanning diverse...
Media Release
January 13, 2022
COLUMBUS, OH, January 13, 2022 – Andelyn Biosciences, a pioneering cell and gene therapy CDMO born out of Nationwide Children’s Hospital, today...
News
November 22, 2021
Andelyn Biosciences has set its sights on Dublin for one of two new labs for the gene therapy company.
Blog
November 11, 2021
Andelyn Biosciences has established a unique network of industry experts across the entire development and commercialization spectrum. In addition to...
Blog
October 22, 2021
Andelyn Biosciences is building the best cell and gene therapy team in spite of a talent shortage and competitive talent...